Rayleen M. Lewis

1.4k total citations · 1 hit paper
19 papers, 888 citations indexed

About

Rayleen M. Lewis is a scholar working on Epidemiology, Surgery and Microbiology. According to data from OpenAlex, Rayleen M. Lewis has authored 19 papers receiving a total of 888 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 14 papers in Surgery and 3 papers in Microbiology. Recurrent topics in Rayleen M. Lewis's work include Cervical Cancer and HPV Research (17 papers), Genital Health and Disease (14 papers) and Hepatitis B Virus Studies (13 papers). Rayleen M. Lewis is often cited by papers focused on Cervical Cancer and HPV Research (17 papers), Genital Health and Disease (14 papers) and Hepatitis B Virus Studies (13 papers). Rayleen M. Lewis collaborates with scholars based in United States, Canada and Australia. Rayleen M. Lewis's co-authors include Lauri E. Markowitz, Julia W. Gargano, Elizabeth R. Unger, Troy D. Querec, Martin Steinau, Emily Weston, Sancta B. St. Cyr, Hillard Weinstock, Anna Satcher Johnson and Felicia M. T. Lewis and has published in prestigious journals such as Annals of Internal Medicine, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Rayleen M. Lewis

18 papers receiving 870 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2018

2021 288 citations Kristen Kreisel, Ian H. Spicknall et al. Sexually Transmitted Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rayleen M. Lewis United States	12	649	274	165	144	123	19	888
Lea E. Widdice United States	13	555 0.9×	260 0.9×	112 0.7×	114 0.8×	72 0.6×	43	674
Jean‐François Laprise Canada	19	824 1.3×	275 1.0×	116 0.7×	216 1.5×	75 0.6×	33	1.0k
Carol Y. Lin United States	13	531 0.8×	141 0.5×	196 1.2×	91 0.6×	145 1.2×	21	915
Sandra O’Reilly United States	8	800 1.2×	429 1.6×	169 1.0×	71 0.5×	94 0.8×	8	959
Staci L. Sudenga United States	14	719 1.1×	372 1.4×	110 0.7×	39 0.3×	42 0.3×	45	903
Minttu M. Rönn United States	15	464 0.7×	137 0.5×	296 1.8×	57 0.4×	178 1.4×	36	841
Aurelio Cruz-Valdéz Mexico	21	1.2k 1.8×	510 1.9×	206 1.2×	78 0.5×	180 1.5×	65	1.6k
Michelle Vichnin United States	11	649 1.0×	233 0.9×	40 0.2×	346 2.4×	91 0.7×	13	941
Ina U. Park United States	20	801 1.2×	500 1.8×	361 2.2×	61 0.4×	107 0.9×	37	1.3k
Sonya Patel United States	7	1.5k 2.3×	713 2.6×	207 1.3×	213 1.5×	90 0.7×	11	1.7k

Countries citing papers authored by Rayleen M. Lewis

Since Specialization

Citations

This map shows the geographic impact of Rayleen M. Lewis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rayleen M. Lewis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rayleen M. Lewis more than expected).

Fields of papers citing papers by Rayleen M. Lewis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rayleen M. Lewis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rayleen M. Lewis. The network helps show where Rayleen M. Lewis may publish in the future.

Co-authorship network of co-authors of Rayleen M. Lewis

This figure shows the co-authorship network connecting the top 25 collaborators of Rayleen M. Lewis. A scholar is included among the top collaborators of Rayleen M. Lewis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rayleen M. Lewis. Rayleen M. Lewis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Brewer, Sarah, Rayleen M. Lewis, Troy D. Querec, Elizabeth R. Unger, & Lauri E. Markowitz. (2025). Evaluation of possible human papillomavirus (HPV) type replacement after vaccine introduction, overall and by race/ethnicity, United States. Vaccine. 62. 127576–127576. 1 indexed citations

Lewis, Rayleen M., et al.. (2024). High impact of quadrivalent human papillomavirus vaccine across racial/ethnic groups: National Health and Nutrition Examination Survey, 2003–2006 and 2015–2018. Human Vaccines & Immunotherapeutics. 20(1). 2308378–2308378. 6 indexed citations

Rosenblum, Hannah G., Rayleen M. Lewis, Julia W. Gargano, et al.. (2022). Human Papillomavirus Vaccine Impact and Effectiveness Through 12 Years After Vaccine Introduction in the United States, 2003 to 2018. Annals of Internal Medicine. 175(7). 918–926. 40 indexed citations

Gargano, Julia W., Nancy McClung, Rayleen M. Lewis, et al.. (2022). HPV type‐specific trends in cervical precancers in the United States, 2008 to 2016. International Journal of Cancer. 152(2). 137–150. 19 indexed citations

Markowitz, Lauri E., Mélanie Drolet, Rayleen M. Lewis, et al.. (2022). Human papillomavirus vaccine effectiveness by number of doses: Updated systematic review of data from national immunization programs. Vaccine. 40(37). 5413–5432. 28 indexed citations

Lewis, Rayleen M. & Lauri E. Markowitz. (2022). Disparities in human papillomavirus vaccination coverage in the United States, National Health and Nutrition Examination Survey, January 2017–March 2020. Vaccine. 40(20). 2828–2832. 7 indexed citations

Rosenblum, Hannah G., Rayleen M. Lewis, Julia W. Gargano, et al.. (2021). Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine — United States, 2003–2018. MMWR Morbidity and Mortality Weekly Report. 70(12). 415–420. 72 indexed citations

Gargano, Julia W., Rayleen M. Lewis, Troy D. Querec, et al.. (2021). Prevalence of Human Papillomavirus Among Women Older than Recommended Age for Vaccination by Birth Cohort, United States 2003‒2016. The Journal of Infectious Diseases. 225(1). 94–104. 6 indexed citations

Lewis, Rayleen M., Jean‐François Laprise, Julia W. Gargano, et al.. (2021). Estimated Prevalence and Incidence of Disease-Associated Human Papillomavirus Types Among 15- to 59-Year-Olds in the United States. Sexually Transmitted Diseases. 48(4). 273–277. 87 indexed citations

10.

Kreisel, Kristen, Ian H. Spicknall, Julia W. Gargano, et al.. (2021). Sexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2018. Sexually Transmitted Diseases. 48(4). 208–214. 288 indexed citations breakdown →

11.

Lewis, Rayleen M., Jami S. Leichliter, Harrell W. Chesson, & Lauri E. Markowitz. (2021). Sexual Behavior Among US Adults: New Sex Partners and Number of Lifetime Sex Partners, NHANES 2013–2016 and NSFG 2011–2015. Sexuality Research and Social Policy. 19(2). 530–540. 1 indexed citations

12.

Lewis, Rayleen M., Julia W. Gargano, Elizabeth R. Unger, Troy D. Querec, & Lauri E. Markowitz. (2021). Genital Human Papillomavirus Prevalence Over the Lifespan Among Females and Males in a National Cross-Sectional Survey, United States, 2013–2016. Sexually Transmitted Diseases. 48(11). 855–863.

13.

McClung, Nancy, Rayleen M. Lewis, Julia W. Gargano, et al.. (2019). Declines in Vaccine-Type Human Papillomavirus Prevalence in Females Across Racial/Ethnic Groups: Data From a National Survey. Journal of Adolescent Health. 65(6). 715–722. 32 indexed citations

14.

Markowitz, Lauri E., Allison L. Naleway, Rayleen M. Lewis, et al.. (2019). Declines in HPV vaccine type prevalence in women screened for cervical cancer in the United States: Evidence of direct and herd effects of vaccination. Vaccine. 37(29). 3918–3924. 42 indexed citations

15.

Markowitz, Lauri E., Allison L. Naleway, Nicola P. Klein, et al.. (2019). Human Papillomavirus Vaccine Effectiveness Against HPV Infection: Evaluation of One, Two, and Three Doses. The Journal of Infectious Diseases. 221(6). 910–918. 51 indexed citations

16.

Lewis, Rayleen M. & Lauri E. Markowitz. (2018). Human papillomavirus vaccination coverage among females and males, National Health and Nutrition Examination Survey, United States, 2007–2016. Vaccine. 36(19). 2567–2573. 45 indexed citations

17.

Lewis, Rayleen M., Lauri E. Markowitz, Gitika Panicker, & Elizabeth R. Unger. (2018). Seroprevalence of Human Papillomavirus 6/11/16/18 Among Self-identified Gay/Bisexual Men Who Have Sex With Men, Men Who Have Sex With Women, and Females, United States, 2003–2010. Clinical Infectious Diseases. 69(6). 1011–1018. 7 indexed citations

18.

Oliver, Sara E., Elizabeth R. Unger, Rayleen M. Lewis, et al.. (2017). Prevalence of Human Papillomavirus Among Females After Vaccine Introduction—National Health and Nutrition Examination Survey, United States, 2003–2014. The Journal of Infectious Diseases. 216(5). 594–603. 114 indexed citations

19.

Lewis, Rayleen M., Lauri E. Markowitz, Julia W. Gargano, Martin Steinau, & Elizabeth R. Unger. (2017). Prevalence of Genital Human Papillomavirus Among Sexually Experienced Males and Females Aged 14–59 Years, United States, 2013–2014. The Journal of Infectious Diseases. 217(6). 869–877. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact